首页> 中文期刊>世界科学技术-中医药现代化 >复方苦参注射液治疗淋巴恶性肿瘤真实世界临床用药人群特征研究

复方苦参注射液治疗淋巴恶性肿瘤真实世界临床用药人群特征研究

     

摘要

目的:基于医院信息系统电子医疗数据,解析复方苦参注射液治疗淋巴恶性肿瘤真实世界临床用药人群特征,为其合理应用提供参考.方法:提取3 674例使用复方苦参注射液治疗淋巴恶性肿瘤患者电子医疗数据,对其一般信息、诊断信息、用药信息进行基于频数与率的描述性分析.结果:患者平均年龄54.95岁;男性多于女性;主要来源科室为肿瘤科、血液科;基于出院转归判定的住院患者临床治疗总有效率66.15%;单次用药剂量以10-20 mL居多;疗程以4-14天为主;联用西药常见品种包括地塞米松、托烷司琼注射液、甲氧氯普胺片、胸腺肽注射液、环磷酰胺注射液等;联用西药常见药理作用包括抗肿瘤化疗药、免疫调节药、糖皮质激素药、抗生素类药等.结论:复方苦参注射液治疗淋巴恶性肿瘤真实世界临床用药剂量、疗程基本符合说明书界定,用药人群特征符合品种定位及淋巴恶性肿瘤疾病规律;基于出院转归判定的住院患者临床疗效较为确切;联合用药类型广泛.%This study was aimed to analyze the clinical characteristics of Compound Kushen Injection in the treatment of patients with malignant lymphoma in the real world based on the electronic medical record,and to provide a reference for its rational application.The electronic medical data of 3 674 patients with malignant lymphoma using Compound Kushen Injection was extracted.General information,diagnostic information,and medication information were analyzed on the basis of frequency and rate of descriptive analysis.The results showed that the average age of patients was 54.95 yearsold,with more males than females.Patients were mainly from the department of oncology and hematology.Based on hospital outcomes in hospitalized patients,the clinical total effective rate was 66.15%.The single medication dosage was mostly 10-20 ml.The course of treatment was mainly 4-14 days.The common western medications in combination included dexamethasone,tropisetron injection,metoclopramide tablet,thymopolypeptides injection,cyclophosphamide injection,and etc.Common pharmacological effects of combined western medicine included anti-tumor chemotherapy drugs,immunomodulatory drugs,glucocorticoid drugs,antibiotic drugs and so on.It was concluded that the clinical dosage,scope of malignant lymphoma treatment using Compound Kushen Injection in the real world were consistent with the specification.And characteristics of the crowd using Compound Kushen injection is clear and in line with the general rule of malignant lymphoma and clinical positioning of varieties.Based on the hospital outcomes,the clinical efficacy is determined to have precise effect on hospitalized patients.The drug combination type is extensive.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号